Only 5-Star Reviews for This Dell Inspiron (i7, 64GB RAM, 2TB SSD), Now 75% Off on Amazon
Powerful laptops (for business and leisure) typically cost a lot of money, and a top-tier configuration easily pushes the price above $2,000. This is why this Dell Inspiron 15 3530 touchscreen 64GB RAM / 2TB SSD storage laptop price is begging attention with its breathtaking… 72% discount on Amazon for $999, down from an original list price of $3,599 ($2,600 off and it's not even Black Friday!).
Besides that incredible price, this all-in-one package also includes Windows 11 Pro for a more secure Windows experience, Microsoft Office Pro with a lifetime license, an external CD/DVD drive, and Wi-Fi 6 connectivity right out of the box. This is definitely one of our favorite laptop deals of 2025 so far.
See at Amazon
Powerful And Reliable Dell Laptop
The basic engine for the Dell Inspiron 15 3530 is a 13th Gen Intel Core i7-1355U processor which has 10 cores (2 performance + 8 efficiency) and 12 threads, supporting turbo speeds up to 5.0 GHz with a 12 MB cache. This processor was designed for efficiency and performance to run multiple applications at the same time including demanding business software. The integrated Intel Iris Xe graphics provide smooth visuals suitable for professional and multimedia tasks.
The 64GB of DDR4 RAM is a standout feature (especially at this price point) and it allows users to run multiple applications simultaneously without a hint of slowdown. Within this class of laptops, most are capped at 16GB or 32GB, so to find a new machine with a 64GB configuration (such as this Inspiron model) is pretty rare and highly valuable.
See at Amazon
In terms of storage, this model exceeds expectations and what you can expect from the market: The 2TB PCIe NVMe SSD allows for speedy boot times and fast file access to handle large projects and media libraries with ease which is impressive by any standard. The inclusion of an external CD/DVD drive is a nice bonus for those who still rely on optical media.
The touchscreen is also responsive (Dell is really good at this) and the keyboard allows the user to type comfortably with limited effort for extended periods of time. The range of ports should also please most users as it has 1x USB 3.2 Gen 1 Type-A, 1x USB 3.2 Gen 1 Type-C, 1x USB 2.0, 1x SD Card Reader, 1x HDMI 1.4, and 1x Headset Jack. The connectivity is great too, bringing Wi-Fi 6 and Bluetooth to guarantee speedy quality in connections.
The 15.6-inch Full HD IPS touchscreen is a treat for both work and play, and you'll absolutely love it. With a 1920×1080 resolution, anti-glare coating and narrow bezels, you'll see exceptional vibrant colors and well-defined details and the added convenience in touch functionality is extremely useful for presentations.
The OS is a huge premium here too, being a certified copy of Windows 11 Pro for advanced security, integrated Microsoft services support, great interactivity, and a great interface that is optimized for productivity. The preinstalled Office Pro Suite with a lifetime license for latest versions of Microsoft Word, Excel, PowerPoint, and countless other productivity and business tools is a great feature.
As a bonus for the office worker/collaborator, the Microsoft Copilot AI is a great new integration tool. As an AI-assisted workflow tool, it is great for accelerating productivity by automating repetitive tasks and making intelligent suggestions for later on and keeping the user organized as a task planner to support productivity. Copilot is implemented to simplify the job and make it both less intimidating and less time-consuming.
If you've been waiting for a sign to upgrade your tech, this might just be it.
See at Amazon
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
Don't regulate us like radio, music streamer Spotify tells CRTC
OTTAWA — Music streamer Spotify says Canada's federal broadcast regulator shouldn't impose rules meant for radio on streaming services. Appearing before a CRTC hearing today, company representatives compared regulating Spotify like a radio station to treating Uber like a horse and buggy. In its written submission, Spotify argued the CRTC doesn't have the jurisdiction to extend rules governing commercial negotiations and disputes in the broadcast sector to online players. The CRTC is holding a hearing on market dynamics as part of its work to implement the Online Streaming Act, which updated broadcasting laws to capture online platforms. During previous hearings, large cable and broadcasting companies like Bell and Rogers called on the CRTC to loosen existing rules for traditional players. They're taking aim at regulations governing how cable channels must be packaged and disputes about carriage of cable channels. This report by The Canadian Press was first published June 20, 2025. Anja Karadeglija, The Canadian Press
Yahoo
30 minutes ago
- Yahoo
Eli Lilly (NYSE:LLY) Faces $7 Billion Lawsuit While Partnering With Innovative Biotech
Eli Lilly has been in the spotlight recently with a 3.96% share price increase over the past month. The selection of RyboDyn Inc. to join Lilly Gateway Labs stands out among recent developments, signaling strengthened research capabilities in precision immunotherapies and potentially bolstering investor confidence. Additionally, the company's legal entanglement with the lawsuit concerning Actos, following a class certification affirmation, highlights ongoing challenges in the pharmaceutical sector. The company's ongoing talks to acquire Verve Therapeutics also show its commitment to growing its gene-editing capabilities. These events have added weight to the broader market's trends. We've identified 2 warning signs for Eli Lilly (1 can't be ignored) that you should be aware of. The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 27 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement. Recent developments at Eli Lilly, such as the RyboDyn Inc. collaboration, have potential implications for its strategic growth, particularly in precision immunotherapies. This aligns with the company's narrative of expanding capabilities in oncology and immunology, indicating possible enhancements in revenue and earnings forecasts over the long term. Additionally, as Eli Lilly progresses with Phase III trials, including those for orforglipron, the anticipated product approvals could bolster revenue avenues by tapping into high-demand markets like diabetes and obesity treatments. Over the past five years, Eli Lilly's total shareholder return was a very large 430.14%, demonstrating substantial long-term growth despite recent underperformance against the US Pharmaceuticals industry, which saw a 8.9% drop over the past year. This impressive five-year return provides context to the company's current position, underscoring a history of robust shareholder value creation. Given the ongoing acquisition talks with Verve Therapeutics and Eli Lilly's significant investment in both manufacturing and R&D, the outlook for future revenue and earnings remains optimistic. However, potential regulatory hurdles and pricing pressures, particularly in the U.S. market, highlight possible challenges. The shares, with a current price of US$775.12, are 21.0% below the analyst consensus target of US$981.63. This discount suggests room for growth, should the company meet or exceed the analyst expectations on revenue and earnings. Learn about Eli Lilly's future growth trajectory here. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:LLY. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
31 minutes ago
- Yahoo
Stellantis Evaluates Maserati's Future, Including Potential Sale -- Reuters
Stellantis (STLA, Financials) is weighing a possible sale of its luxury brand Maserati as part of a broader strategic review, according to a Reuters report citing two unnamed sources familiar with the matter. Warning! GuruFocus has detected 11 Warning Signs with STLA. The discussions reportedly began before newly appointed CEO Antonio Filosa officially takes the helm. Maserati's future is under review as Stellantis navigates a shrinking U.S. market, Chinese competition, and steep tariffs imposed by President Donald Trump on foreign-made cars and parts. Despite the internal review, a Stellantis spokesperson told Reuters that Maserati is not for sale. McKinsey declined to comment. Maserati's sales fell by over 50% last year to 11,300 units, with no new models currently scheduled for launch. A new business plan is expected once Filosa begins his tenure. Stellantis' board remains split on the brand's futuresome directors reportedly view Maserati as a reputational asset, while others believe it lacks viability for a sustainable relaunch. Analysts say streamlining Stellantis' 14-brand portfolio could improve profit margins. The company's shares have lost roughly two-thirds of their value since March 2024. Chinese automakers such as Chery could emerge as potential buyers, echoing earlier moves like Geely's acquisition of Volvo or SAIC's purchase of MG. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
